Search research articles
Contact Us
Filters
Showing results (21-30 of 90) with videos related to
Page
of 9
Sort By:
Molecular Pharmacology
|
April 1, 1995
Inhibition of human 5-phosphoribosyl-1-pyrophosphate synthetase by 4-amino-8-(beta-D-ribofuranosylamino)-pyrimido[5,4-d]pyrimidine-5'- monophosphate: evidence for interaction at the ADP allosteric site
D W Fry, M A Becker, R L Switzer
Cancer Research
|
June 1, 1983
Role of methotrexate polyglutamylation and cellular energy metabolism in inhibition of methotrexate binding to dihydrofolate reductase by 5-formyltetrahydrofolate in Ehrlich ascites tumor cells in vitro
L H Matherly, D W Fry, I D Goldman
The Journal of Biological Chemistry
|
February 25, 1982
Rapid formation of poly-gamma-glutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high pressure liquid chromatography in the Ehrlich ascites tumor cell in vitro
D W Fry, J C Yalowich, I D Goldman
Seminars in Oncology
|
November 14, 2001
CI-1033, a pan-erbB tyrosine kinase inhibitor
W J Slichenmyer, W L Elliott, D W Fry
Cancer Research
|
August 1, 1984
Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier system
D W Fry, J A Besserer, T J Boritzki
Protein Expression and Purification
|
February 1, 1996
Expression, purification and characterization of focal adhesion kinase using a baculovirus system
B E Withers, P R Keller, D W Fry
The Journal of Biological Chemistry
|
May 10, 1981
Adenosine stimulation of uphill adenine transport in L1210 leukemia cells. Evidence for a novel countertransport mechanism
R L Cybulski, D W Fry, I D Goldman
Current Opinion in Oncology
|
November 25, 1997
Inhibitors of tyrosine kinase
W D Klohs, D W Fry, A J Kraker
Plant Physiology
|
November 1, 1983
Isolation, purification, and partial characterization of formate dehydrogenase from soybean seed
M P Farinelli, D W Fry, K E Richardson
Cancer Chemotherapy and Pharmacology
|
January 1, 1984
Studies on the biochemical mechanism of the novel antitumor agent, CI-920
D W Fry, T J Boritzki, R C Jackson
Page
of 9
Search research articles
Search
Showing results (21-30 of 90) with videos related to
Sort By:
Page
of 9
Molecular Pharmacology
|
April 1, 1995
Inhibition of human 5-phosphoribosyl-1-pyrophosphate synthetase by 4-amino-8-(beta-D-ribofuranosylamino)-pyrimido[5,4-d]pyrimidine-5'- monophosphate: evidence for interaction at the ADP allosteric site
D W Fry, M A Becker, R L Switzer
Cancer Research
|
June 1, 1983
Role of methotrexate polyglutamylation and cellular energy metabolism in inhibition of methotrexate binding to dihydrofolate reductase by 5-formyltetrahydrofolate in Ehrlich ascites tumor cells in vitro
L H Matherly, D W Fry, I D Goldman
The Journal of Biological Chemistry
|
February 25, 1982
Rapid formation of poly-gamma-glutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high pressure liquid chromatography in the Ehrlich ascites tumor cell in vitro
D W Fry, J C Yalowich, I D Goldman
Seminars in Oncology
|
November 14, 2001
CI-1033, a pan-erbB tyrosine kinase inhibitor
W J Slichenmyer, W L Elliott, D W Fry
Cancer Research
|
August 1, 1984
Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier system
D W Fry, J A Besserer, T J Boritzki
Protein Expression and Purification
|
February 1, 1996
Expression, purification and characterization of focal adhesion kinase using a baculovirus system
B E Withers, P R Keller, D W Fry
The Journal of Biological Chemistry
|
May 10, 1981
Adenosine stimulation of uphill adenine transport in L1210 leukemia cells. Evidence for a novel countertransport mechanism
R L Cybulski, D W Fry, I D Goldman
Current Opinion in Oncology
|
November 25, 1997
Inhibitors of tyrosine kinase
W D Klohs, D W Fry, A J Kraker
Plant Physiology
|
November 1, 1983
Isolation, purification, and partial characterization of formate dehydrogenase from soybean seed
M P Farinelli, D W Fry, K E Richardson
Cancer Chemotherapy and Pharmacology
|
January 1, 1984
Studies on the biochemical mechanism of the novel antitumor agent, CI-920
D W Fry, T J Boritzki, R C Jackson
Page
of 9